DisruPep in  South Summit 2023

DisruPep participated in the leading investment event in Europe – South Summit – last June 2023. Through the participation of the CataPull innovation program of the Madrid Science Park Foundation (FPCM), we shared a stand with FPCM and CSIC. Where we had the opportunity to present our biotech and our pipeline in the different therapeutic […]

How our PTSD drug candidate works: QBP1 peptide

Post-traumatic stress disorder occurs after a traumatic event through the formation of new proteins and neuronal connections, through the activation of a CPEB3 protein, which is involved in memory consolidation. This occurs mainly in the REM phase of sleep. QBP1 is a peptide that acts as a switch in CPB3 and memory consolidation. We have […]